STOCK TITAN

Windward Bio COO receives 33,206-share stock grant

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

WINDWARD BIO GROUP AG reports that Chief Operating Officer Kevin Andrew Harris received a restricted share unit award covering 33,206 shares on November 16, 2026. His reported direct common-share holdings afterward were 960,966 shares. The company also reports 180,160 employee share options with a $17 exercise price and a November 12, 2036 expiration date.

The RSUs vest in stages beginning May 11, 2027, and the options vest in 36 substantially equal monthly installments beginning December 31, 2026; both schedules are subject to continued service.

Insider Harris Kevin Andrew
Role Chief Operating Officer
Type Security Shares Price Value
Grant/Award Common Shares F1 33,206 $0.00 $0.00
Grant/Award Employee Share Options (Right to Buy) F2 180,160 $0.00 $0.00
Holdings After Transaction: Employee Share Options (Right to Buy) — 180,160 options (Direct); Common Shares — 960,966 shares (Direct)
Holdings Before and After: Employee Share Options (Right to Buy), 360,320 to 180,160 options (Direct); Common Shares, 927,760 to 960,966 shares (Direct)
Footnotes (2)
  1. F1. Represents a restricted share unit ("RSU") award. One quarter (1/4th) of the RSU will vest on May 11, 2027, and the remainder will vest in eight substantially equal installments on each subsequent May 20, August 20, November 20 and February 20, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
  2. F2. This option will vest in 36 substantially equal monthly installments on the last day of the relevant month commencing on December 31, 2026, subject to the Reporting Person's continuous service as of each such vesting date.
RSU award 33,206 shares Awarded November 16, 2026
Direct common shares held 960,966 shares Reported after the November 16, 2026 award
Employee share options 180,160 options Reported November 12, 2026
Exercise price $17 per share Employee share options
restricted share unit ("RSU") award financial
"Represents a restricted share unit ("RSU") award"
Employee Share Options (Right to Buy) financial
"Employee Share Options (Right to Buy)"
substantially equal installments financial
"vest in 36 substantially equal monthly installments"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did WWB COO Kevin Andrew Harris receive in the RSU award?

The RSU award covered 33,206 shares; his reported direct common-share holdings afterward were 960,966 shares.

What are the terms of Kevin Andrew Harris's WWB employee share options?

The reported award covers 180,160 employee share options, with a $17 exercise price and an expiration date of November 12, 2036. The options vest in 36 substantially equal monthly installments beginning December 31, 2026, subject to continued service.

When do Kevin Andrew Harris's WWB RSUs vest?

One quarter of the RSU award vests on May 11, 2027. The remainder vests in eight substantially equal installments on each subsequent May 20, August 20, November 20, and February 20, subject to his continuous service on each vesting date.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Harris Kevin Andrew

(Last)(First)(Middle)
C/O WINDWARD BIO GROUP AG
AESCHENPLATZ 6

(Street)
BASEL4052

(City)(State)(Zip)

SWITZERLAND

(Country)
2. Issuer Name and Ticker or Trading Symbol
WINDWARD BIO GROUP AG [ WWB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Operating Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/12/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Shares11/16/2026A33,206(1)A$0960,966D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Employee Share Options (Right to Buy)$1711/12/2026A180,160 (2)11/12/2036Common Shares180,160$0180,160D
Explanation of Responses:
1. Represents a restricted share unit ("RSU") award. One quarter (1/4th) of the RSU will vest on May 11, 2027, and the remainder will vest in eight substantially equal installments on each subsequent May 20, August 20, November 20 and February 20, subject to the Reporting Person's continuous service to the Issuer on each such vesting date.
2. This option will vest in 36 substantially equal monthly installments on the last day of the relevant month commencing on December 31, 2026, subject to the Reporting Person's continuous service as of each such vesting date.
/s/ Scott Applebaum, Attorney-in-Fact11/16/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading